XTL Biopharmaceutica (Israel) Alpha and Beta Analysis

XTLB Stock  ILS 9.00  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as XTL Biopharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in XTL Biopharmaceutica over a specified time horizon. Remember, high XTL Biopharmaceutica's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to XTL Biopharmaceutica's market risk premium analysis include:
Beta
5.34
Alpha
2.14
Risk
21.79
Sharpe Ratio
0.16
Expected Return
3.58
Please note that although XTL Biopharmaceutica alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., NYSE Composite index.) So in this particular case, XTL Biopharmaceutica did 2.14  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of XTL Biopharmaceuticals stock's relative risk over its benchmark. XTL Biopharmaceuticals has a beta of 5.34  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, XTL Biopharmaceutica will likely underperform. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out XTL Biopharmaceutica Backtesting, XTL Biopharmaceutica Valuation, XTL Biopharmaceutica Correlation, XTL Biopharmaceutica Hype Analysis, XTL Biopharmaceutica Volatility, XTL Biopharmaceutica History and analyze XTL Biopharmaceutica Performance.

XTL Biopharmaceutica Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. XTL Biopharmaceutica market risk premium is the additional return an investor will receive from holding XTL Biopharmaceutica long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in XTL Biopharmaceutica. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate XTL Biopharmaceutica's performance over market.
α2.14   β5.34

XTL Biopharmaceutica expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of XTL Biopharmaceutica's Buy-and-hold return. Our buy-and-hold chart shows how XTL Biopharmaceutica performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

XTL Biopharmaceutica Market Price Analysis

Market price analysis indicators help investors to evaluate how XTL Biopharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading XTL Biopharmaceutica shares will generate the highest return on investment. By understating and applying XTL Biopharmaceutica stock market price indicators, traders can identify XTL Biopharmaceutica position entry and exit signals to maximize returns.

XTL Biopharmaceutica Return and Market Media

The median price of XTL Biopharmaceutica for the period between Thu, Jan 25, 2024 and Wed, Apr 24, 2024 is 3.6 with a coefficient of variation of 57.77. The daily time series for the period is distributed with a sample standard deviation of 3.09, arithmetic mean of 5.35, and mean deviation of 2.67. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About XTL Biopharmaceutica Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including XTL or other stocks. Alpha measures the amount that position in XTL Biopharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards XTL Biopharmaceutica in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, XTL Biopharmaceutica's short interest history, or implied volatility extrapolated from XTL Biopharmaceutica options trading.

Build Portfolio with XTL Biopharmaceutica

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Complementary Tools for XTL Stock analysis

When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
XTL Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of XTL Biopharmaceutica technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of XTL Biopharmaceutica trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...